These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27569762)

  • 1. Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
    Inzaule SC; Ondoa P; Peter T; Mugyenyi PN; Stevens WS; de Wit TFR; Hamers RL
    Lancet Infect Dis; 2016 Nov; 16(11):e267-e275. PubMed ID: 27569762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolving Landscape of HIV Drug Resistance Diagnostics for Expanding Testing in Resource-Limited Settings.
    Inzaule SC; Hamers RL; Paredes R; Yang C; Schuurman R; Rinke de Wit TF
    AIDS Rev; 2017; 19(4):219-230. PubMed ID: 28182618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy.
    Newman H; Breunig L; van Zyl G; Stich A; Preiser W
    J Clin Virol; 2014 Aug; 60(4):387-91. PubMed ID: 24929754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.
    Siedner MJ; Bwana MB; Moosa MS; Paul M; Pillay S; McCluskey S; Aturinda I; Ard K; Muyindike W; Moodley P; Brijkumar J; Rautenberg T; George G; Johnson B; Gandhi RT; Sunpath H; Marconi VC
    HIV Clin Trials; 2017 Jul; 18(4):149-155. PubMed ID: 28720039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early virological failure and drug resistance mutations in a woman on antiretroviral therapy in Eastern Cape, South Africa: a case report.
    Sogbanmu OO; Adeniyi OV; Fuentes YO; Ter Goon D
    J Med Case Rep; 2015 May; 9():106. PubMed ID: 25947544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.
    Sigaloff KC; Hamers RL; Wallis CL; Kityo C; Siwale M; Ive P; Botes ME; Mandaliya K; Wellington M; Osibogun A; Stevens WS; van Vugt M; Rinke de Wit TF;
    J Infect Dis; 2012 Jun; 205(11):1739-44. PubMed ID: 22448003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
    Mulu A; Maier M; Liebert UG
    PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated HIV care in sub-Saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya.
    Hagey JM; Li X; Barr-Walker J; Penner J; Kadima J; Oyaro P; Cohen CR
    AIDS Care; 2018 Dec; 30(12):1477-1487. PubMed ID: 30037312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries.
    Obiako OR; Murktar HM; Ogoina D
    Niger J Med; 2010; 19(4):352-60. PubMed ID: 21526620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on HIV-1 acquired and transmitted drug resistance in Africa.
    Ssemwanga D; Lihana RW; Ugoji C; Abimiku A; Nkengasong J; Dakum P; Ndembi N
    AIDS Rev; 2015; 17(1):3-20. PubMed ID: 25427100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE; Reid CA; Vermund SH
    Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
    Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A;
    Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives.
    Harries AD; Zachariah R; van Oosterhout JJ; Reid SD; Hosseinipour MC; Arendt V; Chirwa Z; Jahn A; Schouten EJ; Kamoto K
    Lancet Infect Dis; 2010 Jan; 10(1):60-5. PubMed ID: 20129150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of antiretroviral treatment and viral suppression among men who have sex with men and transgender women in sub-Saharan Africa in an observational cohort study: HPTN 075.
    Palumbo PJ; Zhang Y; Clarke W; Breaud A; Sivay M; Cummings V; Hamilton EL; Guo X; Ogendo A; Kayange N; Panchia R; Dominguez K; Chen YQ; Sandfort TGM; Eshleman SH
    Int J Infect Dis; 2021 Mar; 104():465-470. PubMed ID: 33440260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.
    Lecher S; Williams J; Fonjungo PN; Kim AA; Ellenberger D; Zhang G; Toure CA; Agolory S; Appiah-Pippim G; Beard S; Borget MY; Carmona S; Chipungu G; Diallo K; Downer M; Edgil D; Haberman H; Hurlston M; Jadzak S; Kiyaga C; MacLeod W; Makumb B; Muttai H; Mwangi C; Mwangi JW; Mwasekaga M; Naluguza M; Ng'Ang'A LW; Nguyen S; Sawadogo S; Sleeman K; Stevens W; Kuritsky J; Hader S; Nkengasong J
    MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(47):1332-1335. PubMed ID: 27906910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing and managing antiretroviral drug resistance.
    Kuritzkes DR
    AIDS Patient Care STDS; 2004 May; 18(5):259-73. PubMed ID: 15186710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.